Cargando…

Enzyme Immunoassay for C. difficile Toxin Reduces Lab ID Events but Fails to Detect Clinically Significant C. difficile Infection

BACKGROUND: The National Health Safety Network (NHSN) requires reporting of Lab ID events for C. difficile infection (CDI) including all positive clinical tests after day three of hospitalization. Nucleic acid amplification tests (NAAT) that detect genes for toxins A and/or B may be overly sensitive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ridgway, Jessica P, Murillo, Cynthia, Marrs, Rachel, Garcia-Houchins, Sylvia, Harper, Clinitka, Bartlett, Allison H, Landon, Emily
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630813/ http://dx.doi.org/10.1093/ofid/ofx163.993

Ejemplares similares

526. An EMR-Based Diagnostic Stewardship Intervention for GI mPCR Aimed at Reducing Inappropriate C. difficile Tests
por: Newman, Margaret E, et al.
Publicado: (2018)

Performance of chromID Clostridium difficile Agar Compared with BBL C. difficile Selective Agar for Detection of C. difficile in Stool Specimens
por: Han, Sang Bong, et al.
Publicado: (2014)

Detection of Clostridium difficile antigen and toxin in stool specimens: Comparison of the C. difficile quik chek complete enzyme immunoassay and GeneXpert C. difficile polymerase chain reaction assay
por: Senok, Abiola C., et al.
Publicado: (2017)

Mold Contamination Due to Construction Dust in Ventilation System Detected During Routine Pre-commissioning Air Sampling
por: Bartlett, Allison H, et al.
Publicado: (2017)

Comparison of ChromID Agar and Clostridium difficile Selective Agar for Effective Isolation of C. difficile from Stool Specimens
por: Shin, Bo-Moon, et al.
Publicado: (2014)

1089. Analytical Performance of an Ultrasensitive Immunoassay for Detection of Clostridium difficile Toxins in Stool
por: Bartolome, Amelita, et al.
Publicado: (2018)

Another surprise in receptor binding of C. difficile toxins
por: Aktories, Klaus
Publicado: (2022)

Sustained Improvement in Hand Hygiene Compliance Using a Decentralized, Technology-Based Approach
por: Landon, Emily, et al.
Publicado: (2017)

Humoral Immune Response to Clostridioides difficile Toxins A and B in Hospitalized Immunocompromised Patients With C difficile Infection
por: Alonso, Carolyn D, et al.
Publicado: (2021)

135. Impact of Clostridioides difficile Toxin Confirmation on Subsequent C. difficile Treatment in a Rural Health System (IT-CDI)
por: Crawford, Jacquelyn, et al.
Publicado: (2023)

Return on Investment: How Infection Preventionists (IPs) Spend Their Time at an Academic Medical Center
por: Marrs, Rachel, et al.
Publicado: (2017)

The Enterotoxicity of Clostridium difficile Toxins
por: Sun, Xingmin, et al.
Publicado: (2010)

The glucosyltransferase activity of C. difficile Toxin B is required for disease pathogenesis
por: Bilverstone, Terry W., et al.
Publicado: (2020)

2366. PCR Followed by Toxin EIA for the Diagnosis of C. difficile Infection
por: Zhang, Yu, et al.
Publicado: (2019)

Impact on toxin production and cell morphology in Clostridium difficile by ridinilazole (SMT19969), a novel treatment for C. difficile infection
por: Bassères, Eugénie, et al.
Publicado: (2016)

Asymptomatic and yet C. difficile-toxin positive? Prevalence and risk factors of carriers of toxigenic Clostridium difficile among geriatric in-patients
por: Nissle, Klaus, et al.
Publicado: (2016)

Endogenous Serum IgG Antibodies to Clostridium difficile Toxin B Are Associated with Protection against C. difficile Infection Recurrence
por: Kelly, Ciaran P, et al.
Publicado: (2017)

507. Degree of Concordance of Clostridium difficile Strains in Adults with Community-Associated C. difficile Infection and Infants With C. difficile Colonization
por: Clayton, Jason A, et al.
Publicado: (2018)

Characterization of the gut microbiome of patients with Clostridioides difficile infection, patients with non–C. difficile diarrhea, and C. difficile–colonized patients
por: Vázquez-Cuesta, Silvia, et al.
Publicado: (2023)

2359. Prospective Feasibility Study for Novel Ultrasensitive Multiplexed Immunoassay for Clostridiodes difficile Toxins A and B
por: Watson, Lauren, et al.
Publicado: (2019)

Comparative Evaluation of Three Immunoassays for the Simultaneous Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxin A/B
por: Kim, Namsu, et al.
Publicado: (2022)

ID Learning Unit: Understanding and Interpreting Testing for Clostridium difficile
por: Solomon, Daniel A., et al.
Publicado: (2014)

Evaluation of Xpert C. difficile, BD MAX Cdiff, IMDx C. difficile for Abbott m2000, and Illumigene C. difficile Assays for Direct Detection of Toxigenic Clostridium difficile in Stool Specimens
por: Shin, Bo-Moon, et al.
Publicado: (2016)

839. Effect of Clostridioides difficile (C. difficile) Toxin Test Reporting on Clinical Treatment and Outcomes of Toxin-Negative PCR-Positive Patients at Five California Hospitals
por: Polage, Christopher R, et al.
Publicado: (2019)

Binding and neutralization of C. difficile toxins A and B by purified clinoptilolite-tuff
por: Ranftler, Carmen, et al.
Publicado: (2021)

An Update on Clostridioides difficile Binary Toxin
por: Martínez-Meléndez, Adrián, et al.
Publicado: (2022)

787. Evaluation of Clostridioides difficile Environmental Contamination Surrounding C. difficile Patients vs. non-C. difficile Patients in Outpatient Infusion Centers
por: Garey, Kevin W, et al.
Publicado: (2020)

Isolation and Identification of Clostridium difficile Using ChromID C. difficile Medium Combined With Gram Staining and PRO Disc Testing: A Proposal for a Simple Culture Process
por: Park, Kyung Sun, et al.
Publicado: (2015)

Circulating Antibody and Memory B-Cell Responses to C. difficile Toxins A and B in Patients with C. difficile-Associated Diarrhoea, Inflammatory Bowel Disease and Cystic Fibrosis
por: Monaghan, Tanya M., et al.
Publicado: (2013)

Clostridioides difficile Biology: Sporulation, Germination, and Corresponding Therapies for C. difficile Infection
por: Zhu, Duolong, et al.
Publicado: (2018)

1092. Tuning Down Clostridioides difficile PCR Sensitivity Reduces Treatment for C. difficile Infection in Toxin-Negative Patients With No Increase in Adverse Outcomes
por: Hitchcock, Matthew, et al.
Publicado: (2018)

627. Differences in C. difficile Toxin A Binding in Humans: Adults vs. Infants
por: Goldman, David, et al.
Publicado: (2018)

781. C.difficile PCR+/ Toxin EIA- treat or not treat? A clinician survey
por: Nath, Sarath G, et al.
Publicado: (2020)

The microbial metabolite Urolithin A reduces C. difficile toxin expression and repairs toxin-induced epithelial damage
por: Ghosh, Sweta, et al.
Publicado: (2023)

Evaluation of a Rapid Membrane Enzyme Immunoassay for the Simultaneous Detection of Glutamate Dehydrogenase and Toxin for the Diagnosis of Clostridium difficile Infection
por: Kim, Heejung, et al.
Publicado: (2014)

Clinical Correlation of a Clostridium difficile Testing Algorithm Reflexing PCR Positive Specimens to Toxin Enzyme Immunoassay (EIA)
por: Rios, Maria Bueno, et al.
Publicado: (2017)

Structure and assembly of the S-layer in C. difficile
por: Lanzoni-Mangutchi, Paola, et al.
Publicado: (2022)

Toxin B is essential for virulence of Clostridium difficile
por: Lyras, Dena, et al.
Publicado: (2009)

An Analysis of Clostridium difficile Environmental Contamination During and After Treatment for C difficile Infection
por: Davies, Kerrie, et al.
Publicado: (2020)

Comprehensive evaluation of chemiluminescent immunoassays for the laboratory diagnosis of Clostridium difficile infection
por: Makristathis, A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_30skmkg6nr1q08jta8sitcti8n